Kenmore, WA, United States of America

Renata Fam

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Renata Fam: Innovator in Therapeutic Delivery Systems

Introduction

Renata Fam is a prominent inventor based in Kenmore, WA (US). She has made significant contributions to the field of drug delivery systems, holding a total of 5 patents. Her work focuses on developing innovative lipid compounds that enhance the delivery of therapeutics.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "Tyrosine-based lipids for delivery of therapeutics." This disclosure provides a range of tyrosine amino acid lipid compounds and compositions that are useful for drug delivery, therapeutics, and the diagnosis and treatment of various diseases and conditions. These amino acid lipid compounds can be utilized for delivering various agents, such as nucleic acid therapeutics, to cells, tissues, organs, and subjects. The second patent is "Arginine-based lipids for delivery of therapeutics." Similar to her first patent, this disclosure presents a range of amino acid lipid compounds and compositions that facilitate drug delivery and therapeutic applications.

Career Highlights

Renata Fam is currently associated with Marina Biotech, Inc., where she continues to innovate in the field of therapeutic delivery systems. Her work has garnered attention for its potential to improve the efficacy of treatments for various medical conditions.

Collaborations

Renata has collaborated with notable professionals in her field, including Steven C Quay and Michael E Houston, Jr. These collaborations have further enhanced her research and development efforts.

Conclusion

Renata Fam is a trailblazer in the development of lipid-based drug delivery systems. Her innovative patents and ongoing work at Marina Biotech, Inc. position her as a key figure in advancing therapeutic technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…